Fennec Pharmaceuticals (FENC) Misses Q3 EPS by 9c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q3 EPS of ($0.02), $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.37 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Omnicom launches Acxiom Fan Graph sports marketing platform
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy